91:@0.895357:0.033217:0.916054:0.033217:0.916054:0.013052:0.895357:0.013052:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056390:0.958557:0.056390:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158618:-0.158618:0.000000:0.000000:0.000000:0.000000:0.242660:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
2. :@0.076190:0.084931:0.092942:0.084931:0.092942:0.069149:0.076190:0.069149:0.008376:0.004188:0.004188
Dyspepsia in patients aged under 60::@0.101394:0.084931:0.372629:0.084931:0.372629:0.068433:0.101394:0.068433:0.010583:0.008769:0.006652:0.009979:0.009676:0.009979:0.006652:0.003629:0.009979:0.004233:0.003629:0.009071:0.004233:0.009979:0.009979:0.004536:0.003629:0.009676:0.009071:0.004536:0.006652:0.004233:0.009979:0.009979:0.009676:0.009979:0.004233:0.009071:0.009071:0.009979:0.009676:0.004838:0.004233:0.008467:0.008467:0.004233
a.  The  indication for  upper endoscopy is the pres-:@0.096359:0.098844:0.480957:0.098844:0.480957:0.083061:0.096359:0.083061:0.010326:0.004188:0.004188:0.006501:0.006441:0.009223:0.009827:0.004188:0.002313:0.003024:0.009223:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.006516:0.004747:0.009903:0.004551:0.004188:0.002313:0.009192:0.010311:0.010311:0.009827:0.004551:0.006516:0.009827:0.009223:0.010357:0.009903:0.005866:0.009782:0.009903:0.010311:0.008104:0.006516:0.003024:0.005866:0.006516:0.005125:0.009223:0.009827:0.006516:0.010311:0.004551:0.009827:0.005866:0.005020
ence of alarm features to exclude upper GI neo-:@0.121563:0.112756:0.480987:0.112756:0.480987:0.096973:0.121563:0.096973:0.009827:0.009223:0.009782:0.009827:0.004400:0.009903:0.004747:0.004400:0.010326:0.003024:0.010326:0.004551:0.014182:0.004400:0.004747:0.009827:0.010326:0.005125:0.009192:0.004551:0.009827:0.005866:0.004385:0.005125:0.009903:0.004400:0.009827:0.007257:0.009782:0.003024:0.009192:0.010357:0.009827:0.004400:0.009192:0.010311:0.010311:0.009827:0.004551:0.004400:0.013184:0.003417:0.004400:0.009223:0.009827:0.009903:0.005020
plasia::@0.121563:0.126668:0.168628:0.126668:0.168628:0.110885:0.121563:0.110885:0.010311:0.003024:0.010326:0.005866:0.003024:0.010326:0.004188
i.  Clinically  significant  weight  loss  (>50  percent :@0.116528:0.140580:0.485175:0.140580:0.485175:0.124798:0.116528:0.124798:0.003024:0.004188:0.004188:0.013804:0.012292:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.003024:0.008104:0.004188:0.003130:0.005866:0.003024:0.010175:0.009223:0.003024:0.003681:0.003681:0.009782:0.010326:0.009223:0.005125:0.004188:0.003115:0.012564:0.009827:0.003024:0.010175:0.009223:0.005125:0.004188:0.003115:0.003024:0.009903:0.005866:0.005866:0.004188:0.003115:0.005579:0.009162:0.008376:0.008376:0.004188:0.003130:0.010311:0.009827:0.004551:0.009782:0.009827:0.009223:0.005125:0.004188
usual body weight over six to 12 months):@0.141731:0.154493:0.436946:0.154493:0.436946:0.138710:0.141731:0.138710:0.009192:0.005866:0.009192:0.010326:0.003024:0.004188:0.010311:0.009903:0.010357:0.008104:0.004188:0.012564:0.009827:0.003024:0.010175:0.009223:0.005125:0.004188:0.009903:0.008376:0.009827:0.004551:0.004188:0.005866:0.003024:0.007257:0.004188:0.005125:0.009903:0.004188:0.008376:0.008376:0.004188:0.014182:0.009903:0.009223:0.005125:0.009223:0.005866:0.005579
ii.  Overt gastro-intestinal bleeding.:@0.116528:0.168405:0.375835:0.168405:0.375835:0.152622:0.116528:0.152622:0.003024:0.003024:0.004188:0.004188:0.010780:0.013138:0.008376:0.009827:0.004551:0.005125:0.004188:0.010175:0.010326:0.005866:0.005125:0.004551:0.009903:0.005020:0.003024:0.009223:0.005125:0.009827:0.005866:0.005125:0.003024:0.009223:0.010326:0.003024:0.004188:0.010311:0.003024:0.009827:0.009827:0.010357:0.003024:0.009223:0.010175:0.004188
iii.  >1 alarm feature:@0.116528:0.182317:0.263651:0.182317:0.263651:0.166534:0.116528:0.166534:0.003024:0.003024:0.003024:0.004188:0.004188:0.007756:0.009162:0.008376:0.004188:0.010326:0.003024:0.010326:0.004551:0.014182:0.004188:0.004747:0.009827:0.010326:0.005125:0.009192:0.004551:0.009827
iv.  Rapidly progressive alarm features:@0.116528:0.196229:0.392768:0.196229:0.392768:0.180447:0.116528:0.180447:0.003024:0.008376:0.004188:0.004188:0.005428:0.009177:0.010326:0.010311:0.003024:0.010357:0.003024:0.008104:0.004188:0.010311:0.004551:0.009903:0.010175:0.004551:0.009827:0.005866:0.005866:0.003024:0.008376:0.009827:0.004188:0.010326:0.003024:0.010326:0.004551:0.014182:0.004188:0.004747:0.009827:0.010326:0.005125:0.009192:0.004551:0.009827:0.005866
GenerAl PrinCiPles:@0.076190:0.228841:0.259500:0.228841:0.259500:0.208676:0.076190:0.208676:0.015522:0.009609:0.013674:0.009609:0.010718:0.013674:0.008131:0.005174:0.010348:0.010718:0.005174:0.013674:0.014413:0.005174:0.010348:0.008131:0.009609:0.009609
1. :@0.076190:0.244526:0.092942:0.244526:0.092942:0.228743:0.076190:0.228743:0.008376:0.004188:0.004188
H. pylori::@0.101394:0.244526:0.163049:0.244526:0.163049:0.228743:0.101394:0.228743:0.010326:0.004188:0.004037:0.010311:0.008104:0.003024:0.009903:0.004551:0.003024:0.004188
 patients should have a non-invasive test for :@0.163049:0.244526:0.485175:0.244526:0.485175:0.228743:0.163049:0.228743:0.004037:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004037:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004037:0.009223:0.010326:0.008376:0.009827:0.004037:0.010326:0.004037:0.009223:0.009903:0.009223:0.005020:0.003024:0.009223:0.008376:0.010326:0.005866:0.003024:0.008376:0.009827:0.004052:0.005125:0.009827:0.005866:0.005125:0.004037:0.004747:0.009903:0.004551:0.004188
H. pylori:@0.101394:0.258438:0.158393:0.258438:0.158393:0.242655:0.101394:0.242655:0.010326:0.004188:0.003568:0.010311:0.008104:0.003024:0.009903:0.004551:0.003024
. FD patients that are :@0.158393:0.258438:0.312954:0.258438:0.312954:0.242655:0.158393:0.242655:0.004188:0.003568:0.007333:0.011249:0.003568:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.003568:0.005125:0.009223:0.010326:0.005125:0.003568:0.010326:0.004551:0.009827:0.004188
H. pylori:@0.312335:0.258438:0.369333:0.258438:0.369333:0.242655:0.312335:0.242655:0.010326:0.004188:0.003568:0.010311:0.008104:0.003024:0.009903:0.004551:0.003024
-positive should :@0.369333:0.258438:0.485145:0.258438:0.485145:0.242655:0.369333:0.242655:0.005020:0.010311:0.009903:0.005866:0.003024:0.005125:0.003024:0.008376:0.009827:0.003583:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004188
be prescribed therapy to treat the infection. :@0.101394:0.272350:0.428948:0.272350:0.428948:0.256567:0.101394:0.256567:0.010311:0.009827:0.004188:0.010311:0.004551:0.009827:0.005866:0.009782:0.004551:0.003024:0.010311:0.009827:0.010357:0.004188:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.005125:0.009903:0.004188:0.005125:0.004551:0.009827:0.010326:0.005125:0.004188:0.005125:0.009223:0.009827:0.004188:0.003024:0.009223:0.004747:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.004188
2.  proton  pump  inhibitors:  patients  should  have  em-:@0.076190:0.286262:0.480942:0.286262:0.480942:0.270480:0.076190:0.270480:0.008376:0.004188:0.004188:0.008452:0.008950:0.004551:0.009903:0.005125:0.009903:0.009223:0.004188:0.003901:0.010311:0.009192:0.014182:0.010311:0.004188:0.003916:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.004188:0.004188:0.003931:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.003916:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004188:0.003916:0.009223:0.010326:0.008376:0.009827:0.004188:0.003916:0.009827:0.014182:0.005020
pirical  ppI  therapy  if they  are :@0.101394:0.300175:0.326380:0.300175:0.326380:0.284392:0.101394:0.284392:0.010311:0.003024:0.004551:0.003024:0.009782:0.010326:0.003024:0.004188:0.002464:0.008950:0.008950:0.003417:0.004188:0.002449:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.002449:0.003024:0.004747:0.006652:0.005125:0.009223:0.009827:0.008104:0.004188:0.002449:0.010326:0.004551:0.009827:0.004188
H. pylori:@0.328845:0.300175:0.388928:0.300175:0.388928:0.284392:0.328845:0.284392:0.010326:0.004188:0.006652:0.010311:0.008104:0.003024:0.009903:0.004551:0.003024
-negative or :@0.388928:0.300175:0.485145:0.300175:0.485145:0.284392:0.388928:0.284392:0.005020:0.009223:0.009827:0.010175:0.010326:0.005125:0.003024:0.008376:0.009827:0.006652:0.009903:0.004551:0.004188
who remain symptomatic after :@0.101394:0.314087:0.332579:0.314087:0.332579:0.298304:0.101394:0.298304:0.012564:0.009223:0.009903:0.004551:0.004551:0.009827:0.014182:0.010326:0.003024:0.009223:0.004566:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.010326:0.005125:0.003024:0.009782:0.004551:0.010326:0.004747:0.005125:0.009827:0.004551:0.004188
H. pylori:@0.332942:0.314087:0.390923:0.314087:0.390923:0.298304:0.332942:0.298304:0.010326:0.004188:0.004551:0.010311:0.008104:0.003024:0.009903:0.004551:0.003024
 eradication :@0.390923:0.314087:0.485130:0.314087:0.485130:0.298304:0.390923:0.298304:0.004551:0.009827:0.004551:0.010326:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
therapy. In patients with epigastric pain syndrome, :@0.101394:0.327999:0.485130:0.327999:0.485130:0.312216:0.101394:0.312216:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.005896:0.003417:0.009223:0.005896:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005896:0.012564:0.003024:0.005125:0.009223:0.005896:0.009827:0.010311:0.003024:0.010175:0.010326:0.005866:0.005125:0.004551:0.003024:0.009782:0.005896:0.010311:0.010326:0.003024:0.009223:0.005912:0.005866:0.008104:0.009223:0.010357:0.004551:0.009903:0.014182:0.009827:0.004188:0.004188
acid-suppression  therapy  is  a  first-line  therapy  and :@0.101394:0.341911:0.485145:0.341911:0.485145:0.326129:0.101394:0.326129:0.010326:0.009782:0.003024:0.010357:0.005020:0.005866:0.009192:0.010311:0.010311:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.004188:0.002495:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.002480:0.003024:0.005866:0.004188:0.002495:0.010326:0.004188:0.002480:0.003681:0.003681:0.004551:0.005866:0.005125:0.005020:0.003024:0.003024:0.009223:0.009827:0.004188:0.002480:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.002480:0.010326:0.009223:0.010357:0.004188
an H2 blocker should be considered when the pro-:@0.101394:0.355824:0.480972:0.355824:0.480972:0.340041:0.101394:0.340041:0.010326:0.009223:0.005140:0.010326:0.008376:0.005140:0.010311:0.003024:0.009903:0.009782:0.007590:0.009827:0.004551:0.005140:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005140:0.010311:0.009827:0.005140:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.009827:0.010357:0.005140:0.012564:0.009223:0.009827:0.009223:0.005140:0.005125:0.009223:0.009827:0.005140:0.010311:0.004551:0.009903:0.005020
ton pump inhibitor fails.:@0.101394:0.369736:0.270788:0.369736:0.270788:0.353953:0.101394:0.353953:0.005125:0.009903:0.009223:0.004188:0.010311:0.009192:0.014182:0.010311:0.004188:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.004188:0.004747:0.010326:0.003024:0.003024:0.005866:0.004188
3.  prokinetics: Those patients not responding to  ppI or :@0.076190:0.383648:0.485206:0.383648:0.485206:0.367866:0.076190:0.367866:0.008225:0.004037:0.004188:0.008754:0.008799:0.004400:0.009752:0.007439:0.002873:0.009071:0.009676:0.004974:0.002873:0.009631:0.005715:0.004037:0.006804:0.006290:0.009071:0.009752:0.005715:0.009676:0.006804:0.010160:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.005715:0.006804:0.009071:0.009752:0.004974:0.006804:0.004400:0.009676:0.005715:0.010160:0.009752:0.009071:0.010205:0.002873:0.009071:0.010024:0.006804:0.004974:0.009752:0.004188:0.002616:0.008799:0.008799:0.003266:0.006804:0.009752:0.004551:0.004188
H. pylori:@0.101394:0.397560:0.159254:0.397560:0.159254:0.381778:0.101394:0.381778:0.010175:0.004037:0.005488:0.010160:0.007953:0.002873:0.009752:0.004400:0.003024
 eradication therapy should be offered pro-:@0.159103:0.397560:0.480972:0.397560:0.480972:0.381778:0.159103:0.381778:0.005488:0.009676:0.004400:0.010175:0.010205:0.002873:0.009631:0.010175:0.004974:0.002873:0.009752:0.009071:0.005488:0.004974:0.009071:0.009676:0.004400:0.010175:0.010160:0.007953:0.005488:0.005715:0.009071:0.009752:0.009041:0.002873:0.010205:0.005488:0.010160:0.009676:0.005488:0.009752:0.004596:0.004596:0.009676:0.004400:0.009676:0.010205:0.005488:0.010160:0.004400:0.009752:0.005020
kinetic therapy. In postprandial distress syndrome, a :@0.101394:0.411473:0.485160:0.411473:0.485160:0.395690:0.101394:0.395690:0.007439:0.002873:0.009071:0.009676:0.004974:0.002873:0.009631:0.005881:0.004974:0.009071:0.009676:0.004400:0.010175:0.010160:0.007953:0.004037:0.005881:0.003266:0.009071:0.005881:0.010160:0.009752:0.005715:0.004974:0.010160:0.004400:0.010175:0.009071:0.010205:0.002873:0.010175:0.002873:0.005881:0.010205:0.002873:0.005715:0.004974:0.004400:0.009676:0.005715:0.005715:0.005881:0.005715:0.007953:0.009071:0.010205:0.004400:0.009752:0.014030:0.009676:0.004037:0.005881:0.010326:0.004188
prokinetic is preferred (in  south Africa, we are cur-:@0.101394:0.425385:0.480972:0.425385:0.480972:0.409602:0.101394:0.409602:0.010160:0.004400:0.009752:0.007439:0.002873:0.009071:0.009676:0.004974:0.002873:0.009631:0.006773:0.002873:0.005715:0.006773:0.010160:0.004400:0.009676:0.004596:0.009676:0.004400:0.004400:0.009676:0.010205:0.006773:0.005428:0.002873:0.009071:0.004188:0.002585:0.007378:0.009752:0.009041:0.004974:0.009071:0.006773:0.011037:0.004596:0.004400:0.002873:0.009631:0.010175:0.004037:0.006773:0.012413:0.009676:0.006773:0.010175:0.004400:0.009676:0.006773:0.009631:0.009041:0.004400:0.005020
rently limited to metoclopramide and domperidone).:@0.101394:0.439297:0.480957:0.439297:0.480957:0.423515:0.101394:0.423515:0.004400:0.009676:0.009071:0.004974:0.002873:0.007953:0.003462:0.002873:0.002873:0.014030:0.002873:0.004974:0.009676:0.010205:0.003462:0.004974:0.009752:0.003462:0.014030:0.009676:0.004974:0.009752:0.009631:0.002873:0.009752:0.010160:0.004400:0.010175:0.014030:0.002873:0.010205:0.009676:0.003462:0.010175:0.009071:0.010205:0.003462:0.010205:0.009752:0.014030:0.010160:0.009676:0.004400:0.002873:0.010205:0.009752:0.009071:0.009676:0.005428:0.004188
4.  Tricyclic antidepressants: Non-responders  to  ppI  or :@0.076190:0.453210:0.485145:0.453210:0.485145:0.437427:0.076190:0.437427:0.008376:0.004188:0.004188:0.008452:0.006441:0.004551:0.003024:0.009782:0.008104:0.009782:0.003024:0.003024:0.009782:0.007333:0.010326:0.009223:0.005125:0.003024:0.010357:0.009827:0.010311:0.004551:0.009827:0.005866:0.005866:0.010326:0.009223:0.005125:0.005866:0.004188:0.007333:0.011188:0.009903:0.009223:0.005020:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.010357:0.009827:0.004551:0.005866:0.004188:0.003130:0.005125:0.009903:0.004188:0.003115:0.008950:0.008950:0.003417:0.004188:0.003130:0.009903:0.004551:0.004188
H. pylori:@0.101394:0.467122:0.161084:0.467122:0.161084:0.451339:0.101394:0.451339:0.010326:0.004188:0.006259:0.010311:0.008104:0.003024:0.009903:0.004551:0.003024
 eradication therapy should be offered tri-:@0.161084:0.467122:0.480942:0.467122:0.480942:0.451339:0.161084:0.451339:0.006259:0.009827:0.004551:0.010326:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.006259:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.006259:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.006259:0.010311:0.009827:0.006259:0.009903:0.004747:0.004747:0.009827:0.004551:0.009827:0.010357:0.006244:0.005125:0.004551:0.003024:0.005020
cyclic antidepressant (TCA) therapy. In postprandial :@0.101394:0.481034:0.485145:0.481034:0.485145:0.465251:0.101394:0.465251:0.009782:0.008104:0.009782:0.003024:0.003024:0.009782:0.003886:0.010326:0.009223:0.005125:0.003024:0.010357:0.009827:0.010311:0.004551:0.009827:0.005866:0.005866:0.010326:0.009223:0.005125:0.003870:0.005579:0.006441:0.012292:0.011188:0.005579:0.003870:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.003870:0.003417:0.009223:0.003870:0.010311:0.009903:0.005866:0.005125:0.010311:0.004551:0.010326:0.009223:0.010357:0.003024:0.010326:0.003024:0.004188
distress syndrome, second-line therapy after proki-:@0.101394:0.494946:0.480972:0.494946:0.480972:0.479164:0.101394:0.479164:0.010357:0.003024:0.005866:0.005125:0.004551:0.009827:0.005866:0.005866:0.007076:0.005866:0.008104:0.009223:0.010357:0.004551:0.009903:0.014182:0.009827:0.004188:0.007076:0.005866:0.009827:0.009782:0.009903:0.009223:0.010357:0.005020:0.003024:0.003024:0.009223:0.009827:0.007076:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.007076:0.010326:0.004747:0.005125:0.009827:0.004551:0.007076:0.010311:0.004551:0.009903:0.007590:0.003024:0.005020
netics includes administration  of  a tricyclic antide-:@0.101394:0.508859:0.480957:0.508859:0.480957:0.493076:0.101394:0.493076:0.009223:0.009827:0.005125:0.003024:0.009782:0.005866:0.006516:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.005866:0.006516:0.010326:0.010357:0.014182:0.003024:0.009223:0.003024:0.005866:0.005125:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.002313:0.009903:0.004747:0.004188:0.002313:0.010326:0.006516:0.005125:0.004551:0.003024:0.009782:0.008104:0.009782:0.003024:0.003024:0.009782:0.006516:0.010326:0.009223:0.005125:0.003024:0.010357:0.009827:0.005020
pressant in low doses, but not a selective serotonin :@0.101394:0.522771:0.485130:0.522771:0.485130:0.506988:0.101394:0.506988:0.010311:0.004551:0.009827:0.005866:0.005866:0.010326:0.009223:0.005125:0.005518:0.003024:0.009223:0.005518:0.003024:0.009903:0.012564:0.005518:0.010357:0.009903:0.005866:0.009827:0.005866:0.004188:0.005518:0.010311:0.009192:0.005125:0.005518:0.009223:0.009903:0.005125:0.005518:0.010326:0.005534:0.005866:0.009827:0.003024:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.005534:0.005866:0.009827:0.004551:0.009903:0.005125:0.009903:0.009223:0.003024:0.009223:0.004188
reuptake inhibitor (ssRI).:@0.101394:0.536683:0.276926:0.536683:0.276926:0.520900:0.101394:0.520900:0.004551:0.009827:0.009192:0.010311:0.005125:0.010326:0.007590:0.009827:0.004188:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.004188:0.005579:0.007529:0.007529:0.009177:0.003417:0.005579:0.004188
5.  psychological therapy:  FD patients not  responding :@0.076190:0.550595:0.485145:0.550595:0.485145:0.534813:0.076190:0.534813:0.008376:0.004188:0.004188:0.008452:0.008950:0.005866:0.008104:0.009782:0.009223:0.009903:0.003024:0.009903:0.010175:0.003024:0.009782:0.010326:0.003024:0.006547:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.004188:0.002343:0.007333:0.011249:0.006547:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006547:0.009223:0.009903:0.005125:0.004188:0.002343:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.010357:0.003024:0.009223:0.010175:0.004188
to  drug therapy should be offered  psychological :@0.101394:0.564508:0.485145:0.564508:0.485145:0.548725:0.101394:0.548725:0.005125:0.009903:0.004188:0.003916:0.010357:0.004551:0.009192:0.010175:0.008119:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.008119:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.008119:0.010311:0.009827:0.008119:0.009903:0.004747:0.004747:0.009827:0.004551:0.009827:0.010357:0.004188:0.003916:0.010311:0.005866:0.008104:0.009782:0.009223:0.009903:0.003024:0.009903:0.010175:0.003024:0.009782:0.010326:0.003024:0.004188
therapies. :@0.101394:0.578420:0.177851:0.578420:0.177851:0.562637:0.101394:0.562637:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.003024:0.009827:0.005866:0.004188:0.004188
patients with continued symptoms of dyspepsia  de-:@0.090478:0.592332:0.480942:0.592332:0.480942:0.576550:0.090478:0.576550:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006667:0.012564:0.003024:0.005125:0.009223:0.006667:0.009782:0.009903:0.009223:0.005125:0.003024:0.009223:0.009192:0.009827:0.010357:0.006667:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.006667:0.009903:0.004747:0.006667:0.010357:0.008104:0.005866:0.010311:0.009827:0.010311:0.005866:0.003024:0.010326:0.004188:0.002495:0.010357:0.009827:0.005020
spite a trial of a tricyclic antidepressant and prokinetic :@0.076190:0.606244:0.485160:0.606244:0.485160:0.590462:0.076190:0.590462:0.005866:0.010311:0.003024:0.005125:0.009827:0.005231:0.010326:0.005231:0.005125:0.004551:0.003024:0.010326:0.003024:0.005231:0.009903:0.004747:0.005216:0.010326:0.005231:0.005125:0.004551:0.003024:0.009782:0.008104:0.009782:0.003024:0.003024:0.009782:0.005231:0.010326:0.009223:0.005125:0.003024:0.010357:0.009827:0.010311:0.004551:0.009827:0.005866:0.005866:0.010326:0.009223:0.005125:0.005231:0.010326:0.009223:0.010357:0.005231:0.010311:0.004551:0.009903:0.007590:0.003024:0.009223:0.009827:0.005125:0.003024:0.009782:0.004188
should undergo endoscopic evaluation with an upper :@0.076190:0.620157:0.485160:0.620157:0.485160:0.604374:0.076190:0.604374:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005670:0.009192:0.009223:0.010357:0.009827:0.004551:0.010175:0.009888:0.005670:0.009827:0.009223:0.010357:0.009903:0.005866:0.009782:0.009903:0.010311:0.003024:0.009782:0.005655:0.009827:0.008376:0.010326:0.003024:0.009192:0.010326:0.005125:0.003024:0.009903:0.009223:0.005670:0.012564:0.003024:0.005125:0.009223:0.005670:0.010326:0.009223:0.005670:0.009192:0.010311:0.010311:0.009827:0.004551:0.004188
endoscopy and biopsies, if not  previously performed. :@0.076190:0.634069:0.485145:0.634069:0.485145:0.618286:0.076190:0.618286:0.009827:0.009223:0.010357:0.009903:0.005866:0.009782:0.009903:0.010311:0.008104:0.007106:0.010326:0.009223:0.010357:0.007106:0.010311:0.003024:0.009903:0.010311:0.005866:0.003024:0.009827:0.005866:0.004188:0.007106:0.003024:0.004747:0.007106:0.009223:0.009903:0.005125:0.004188:0.002903:0.010311:0.004551:0.009827:0.008376:0.003024:0.009903:0.009192:0.005866:0.003024:0.008104:0.007106:0.010311:0.009827:0.004551:0.004747:0.009903:0.004551:0.014182:0.009827:0.010357:0.004188:0.004188
Further evaluation for an alternate diagnosis should be :@0.076190:0.647981:0.485130:0.647981:0.485130:0.632199:0.076190:0.632199:0.007333:0.009192:0.004551:0.005125:0.009223:0.009827:0.004551:0.004989:0.009827:0.008376:0.010326:0.003024:0.009192:0.010326:0.005125:0.003024:0.009903:0.009223:0.005004:0.004747:0.009903:0.004551:0.005004:0.010326:0.009223:0.005004:0.010326:0.003024:0.005125:0.009827:0.004551:0.009223:0.010326:0.005125:0.009827:0.005004:0.010357:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.003024:0.005866:0.005020:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005004:0.010311:0.009827:0.004188
performed  selectively, based on the patient’s symp-:@0.076190:0.661893:0.480927:0.661893:0.480927:0.646111:0.076190:0.646111:0.010311:0.009827:0.004551:0.004747:0.009903:0.004551:0.014182:0.009827:0.010357:0.004188:0.003946:0.005866:0.009827:0.003024:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.003024:0.008104:0.004188:0.008149:0.010311:0.010326:0.005866:0.009827:0.010357:0.008149:0.009903:0.009223:0.008149:0.005125:0.009223:0.009827:0.008149:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005307:0.005866:0.008149:0.005866:0.008104:0.014182:0.010311:0.005020
toms.  patients with continued  symptoms of  dyspepsia :@0.076190:0.675806:0.485115:0.675806:0.485115:0.660023:0.076190:0.660023:0.005125:0.009903:0.014182:0.005866:0.004188:0.004188:0.002510:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006713:0.012564:0.003024:0.005125:0.009223:0.006713:0.009782:0.009903:0.009223:0.005125:0.003024:0.009223:0.009192:0.009827:0.010357:0.004188:0.002510:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.006713:0.009903:0.004747:0.004188:0.002510:0.010357:0.008104:0.005866:0.010311:0.009827:0.010311:0.005866:0.003024:0.010326:0.004188
for three months with symptom onset at least six months :@0.076190:0.689718:0.485130:0.689718:0.485130:0.673935:0.076190:0.673935:0.004747:0.009903:0.004551:0.004067:0.005125:0.009223:0.004551:0.009827:0.009812:0.004082:0.014182:0.009903:0.009223:0.005125:0.009207:0.005866:0.004082:0.012564:0.003024:0.005125:0.009223:0.004067:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.004067:0.009903:0.009223:0.005866:0.009827:0.005125:0.004067:0.010326:0.005125:0.004067:0.003024:0.009827:0.010326:0.005866:0.005125:0.004082:0.005866:0.003024:0.007257:0.004082:0.014182:0.009903:0.009223:0.005125:0.009223:0.005866:0.004188
before diagnosis and no evidence of structural disease :@0.076190:0.703630:0.485130:0.703630:0.485130:0.687848:0.076190:0.687848:0.010311:0.009827:0.004747:0.009903:0.004551:0.009827:0.004581:0.010357:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.003024:0.005866:0.004581:0.010326:0.009223:0.010357:0.004581:0.009223:0.009903:0.004581:0.009827:0.008376:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.004581:0.009903:0.004747:0.004581:0.005866:0.005125:0.004551:0.009192:0.009782:0.005125:0.009192:0.004551:0.010326:0.003024:0.004581:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188
to  explain the  symptoms, should be diagnosed and :@0.076190:0.717543:0.485145:0.717543:0.485145:0.701760:0.076190:0.701760:0.005125:0.009903:0.004188:0.004112:0.009827:0.007257:0.010311:0.003024:0.010326:0.003024:0.009223:0.008315:0.005125:0.009223:0.009827:0.004188:0.004112:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004188:0.008315:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.008315:0.010311:0.009827:0.008315:0.010357:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.009827:0.010357:0.008315:0.010326:0.009223:0.010357:0.004188
treated as having functional dyspepsia.:@0.076190:0.731455:0.366370:0.731455:0.366370:0.715672:0.076190:0.715672:0.005125:0.004551:0.009827:0.010326:0.005125:0.009827:0.010357:0.004188:0.010326:0.005866:0.004188:0.009223:0.010326:0.008376:0.003024:0.009223:0.010175:0.004188:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.004188:0.010357:0.008104:0.005866:0.010311:0.009827:0.010311:0.005866:0.003024:0.010326:0.004188
11:@0.366368:0.725968:0.376084:0.725968:0.376084:0.716814:0.366368:0.716814:0.004858:0.004858
The diagnosis and management of patients with func-:@0.090476:0.745174:0.480940:0.745174:0.480940:0.729391:0.090476:0.729391:0.006441:0.009223:0.009827:0.003356:0.010357:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.003024:0.005866:0.003372:0.010326:0.009223:0.010357:0.003356:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.014182:0.009827:0.009223:0.005125:0.003356:0.009903:0.004747:0.003356:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.003356:0.012564:0.003024:0.005125:0.009223:0.003356:0.004747:0.009192:0.009223:0.009782:0.005020
tional dyspepsia poses a clinical challenge.:@0.076189:0.759086:0.393673:0.759086:0.393673:0.743303:0.076189:0.743303:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.004188:0.010357:0.008104:0.005866:0.010311:0.009827:0.010311:0.005866:0.003024:0.010326:0.004188:0.010311:0.009903:0.005866:0.009827:0.005866:0.004188:0.010326:0.004188:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004188:0.009782:0.009223:0.010326:0.003024:0.003024:0.009827:0.009223:0.010175:0.009827:0.004188
referenCes:@0.076190:0.791735:0.182628:0.791735:0.182628:0.771570:0.076190:0.771570:0.010718:0.009609:0.008870:0.009609:0.010718:0.009609:0.013674:0.014413:0.009609:0.009609
1. :@0.076190:0.803425:0.089220:0.803425:0.089220:0.791150:0.076190:0.791150:0.006515:0.003257:0.003257
Loyd RA,  McClellan DA. Update on  the  evaluation and man-:@0.101390:0.803425:0.480956:0.803425:0.480956:0.791150:0.101390:0.791150:0.005433:0.007702:0.006303:0.008055:0.006997:0.007138:0.008702:0.003257:0.003257:0.003728:0.010807:0.007608:0.009560:0.002352:0.007644:0.002352:0.002352:0.008032:0.007173:0.006997:0.008749:0.008702:0.003257:0.006997:0.007702:0.008020:0.008055:0.008032:0.003986:0.007644:0.006997:0.007702:0.007173:0.003257:0.003728:0.003986:0.007173:0.007644:0.003257:0.003728:0.007644:0.006515:0.008032:0.002352:0.007150:0.008032:0.003986:0.002352:0.007702:0.007173:0.006997:0.008032:0.007173:0.008055:0.006997:0.011030:0.008032:0.007173:0.003904
agement  of  functional  dyspepsia. :@0.101390:0.814129:0.305484:0.814129:0.305484:0.801853:0.101390:0.801853:0.008032:0.007914:0.007644:0.011030:0.007644:0.007173:0.003986:0.003257:0.002740:0.007702:0.003692:0.003257:0.002740:0.003692:0.007150:0.007173:0.007608:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.003257:0.002740:0.008055:0.006303:0.004563:0.008020:0.007644:0.008020:0.004563:0.002352:0.008032:0.003257:0.003257
Am Fam Physician. :@0.308236:0.814129:0.423759:0.814129:0.423759:0.801853:0.308236:0.801853:0.008702:0.011030:0.005997:0.005703:0.008032:0.011030:0.005997:0.006961:0.007173:0.006303:0.004563:0.002352:0.007608:0.002352:0.008032:0.007173:0.003257:0.003257
2011  Mar :@0.426498:0.814129:0.484201:0.814129:0.484201:0.801853:0.426498:0.801853:0.006515:0.006515:0.006515:0.006515:0.003257:0.002752:0.010807:0.008032:0.003540:0.003257
1;83(5):547-552.:@0.101390:0.824833:0.188891:0.824833:0.188891:0.812557:0.101390:0.812557:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
2. :@0.076190:0.835537:0.089220:0.835537:0.089220:0.823261:0.076190:0.823261:0.006515:0.003257:0.003257
Drossman DA. Functional gastrointestinal disorders: History, patho-:@0.101390:0.835537:0.480944:0.835537:0.480944:0.823261:0.101390:0.823261:0.008749:0.003540:0.007702:0.004563:0.004563:0.011030:0.008032:0.007173:0.004516:0.008749:0.008702:0.003257:0.004516:0.005703:0.007150:0.007173:0.007608:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.004516:0.007914:0.008032:0.004563:0.003986:0.003540:0.007702:0.002352:0.007173:0.003986:0.007644:0.004563:0.003986:0.002352:0.007173:0.008032:0.002352:0.004516:0.008055:0.002352:0.004563:0.007702:0.003540:0.008055:0.007644:0.003540:0.004563:0.003257:0.004516:0.008032:0.002352:0.004563:0.003986:0.007702:0.003540:0.006303:0.003257:0.004516:0.008020:0.008032:0.003986:0.007173:0.007702:0.003904
physiology, clinical features, and Rome IV. :@0.101390:0.846241:0.372194:0.846241:0.372194:0.833965:0.101390:0.833965:0.008020:0.007173:0.006303:0.004563:0.002352:0.007702:0.002352:0.007702:0.007914:0.006303:0.003257:0.008725:0.007608:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.008725:0.003692:0.007644:0.008032:0.003986:0.007150:0.003540:0.007644:0.004563:0.003257:0.008725:0.008032:0.007173:0.008055:0.008725:0.007138:0.007702:0.011030:0.007644:0.008725:0.002658:0.008255:0.003257:0.003257
Gastroenterology.:@0.377662:0.846241:0.480956:0.846241:0.480956:0.833965:0.377662:0.833965:0.010254:0.008032:0.004563:0.003986:0.003540:0.007702:0.007644:0.007173:0.003986:0.007644:0.003540:0.007702:0.002352:0.007702:0.007914:0.006303:0.003257
 :@0.480956:0.846241:0.484213:0.846241:0.484213:0.833965:0.480956:0.833965:0.003257
2016;150:1262-1279:@0.101390:0.856944:0.209529:0.856944:0.209529:0.844669:0.101390:0.844669:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.006515
3. :@0.076190:0.867900:0.089220:0.867900:0.089220:0.855624:0.076190:0.855624:0.006515:0.003257:0.003257
Drossman DA, Hasler, WL. Rome IV – functional GI orders: disorders :@0.101390:0.867900:0.484201:0.867900:0.484201:0.855624:0.101390:0.855624:0.008749:0.003540:0.007702:0.004563:0.004563:0.011030:0.008032:0.007173:0.003739:0.008749:0.008702:0.003257:0.003728:0.008032:0.008032:0.004563:0.002352:0.007644:0.003540:0.003257:0.003739:0.011289:0.005433:0.003257:0.003728:0.007138:0.007702:0.011030:0.007644:0.003728:0.002658:0.008255:0.003739:0.005880:0.003739:0.003692:0.007150:0.007173:0.007608:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.003739:0.010254:0.002658:0.003739:0.007702:0.003540:0.008055:0.007644:0.003540:0.004563:0.003257:0.003728:0.008055:0.002352:0.004563:0.007702:0.003540:0.008055:0.007644:0.003540:0.004563:0.003257
of gut-brain interaction. :@0.101390:0.878855:0.243148:0.878855:0.243148:0.866580:0.101390:0.866580:0.007702:0.003692:0.005115:0.007914:0.007150:0.003986:0.003904:0.008020:0.003540:0.008032:0.002352:0.007173:0.005115:0.002352:0.007173:0.003986:0.007644:0.003540:0.008032:0.007608:0.003986:0.002352:0.007702:0.007173:0.003257:0.003257
Gastroenterology.:@0.244994:0.878855:0.348276:0.878855:0.348276:0.866580:0.244994:0.866580:0.010254:0.008032:0.004563:0.003986:0.003540:0.007702:0.007644:0.007173:0.003986:0.007644:0.003540:0.007691:0.002352:0.007702:0.007914:0.006303:0.003257
 2016  May;150(6):1257-:@0.348276:0.878855:0.480932:0.878855:0.480932:0.866580:0.348276:0.866580:0.005115:0.006515:0.006515:0.006515:0.006515:0.003257:0.001870:0.010807:0.008032:0.006303:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904
61. doi: 10.1053/j.gastro.2016.03.035.:@0.101390:0.889811:0.306084:0.889811:0.306084:0.877535:0.101390:0.877535:0.006515:0.006515:0.003257:0.003257:0.008055:0.007702:0.002352:0.003257:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.005139:0.002387:0.003257:0.007914:0.008032:0.004563:0.003986:0.003540:0.007702:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003257
4. :@0.076190:0.900766:0.089220:0.900766:0.089220:0.888490:0.076190:0.888490:0.006515:0.003257:0.003257
Drossman DA. Biopsychosocial overview of functional GI disorders.:@0.101390:0.900766:0.480956:0.900766:0.480956:0.888490:0.101390:0.888490:0.008749:0.003540:0.007702:0.004563:0.004563:0.011030:0.008032:0.007173:0.003751:0.008749:0.008702:0.003257:0.003751:0.006750:0.002352:0.007702:0.008020:0.004563:0.006303:0.007608:0.007173:0.007702:0.004563:0.007702:0.007608:0.002352:0.008032:0.002352:0.003751:0.007702:0.006515:0.007644:0.003540:0.006515:0.002352:0.007644:0.009772:0.003751:0.007702:0.003692:0.003739:0.003692:0.007150:0.007173:0.007608:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.003751:0.010254:0.002658:0.003751:0.008055:0.002352:0.004563:0.007702:0.003540:0.008055:0.007644:0.003540:0.004563:0.003257
Gastroenterology. :@0.101390:0.911721:0.207941:0.911721:0.207941:0.899446:0.101390:0.899446:0.010254:0.008032:0.004563:0.003986:0.003540:0.007702:0.007644:0.007173:0.003986:0.007644:0.003540:0.007702:0.002352:0.007702:0.007914:0.006303:0.003257:0.003257
Volume 150. 2016 May;1272-1278:@0.207929:0.911721:0.395113:0.911721:0.395113:0.899446:0.207929:0.899446:0.008255:0.007702:0.002352:0.007150:0.011030:0.007644:0.003257:0.006515:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.010807:0.008032:0.006303:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.006515
5. :@0.076202:0.922677:0.089231:0.922677:0.089231:0.910401:0.076202:0.910401:0.006515:0.003257:0.003257
Aro p, :@0.101402:0.922677:0.138103:0.922677:0.138103:0.910401:0.101402:0.910401:0.008702:0.003540:0.007702:0.003281:0.006961:0.003257:0.003257
et al.:@0.138126:0.922677:0.166678:0.922677:0.166678:0.910401:0.138126:0.910401:0.007644:0.003986:0.003281:0.008032:0.002352:0.003257
 peptic ulcer disease in a general adult population. The :@0.166678:0.922677:0.484225:0.922677:0.484225:0.910401:0.166678:0.910401:0.003293:0.006961:0.007644:0.008020:0.003986:0.002352:0.007608:0.003281:0.007150:0.002352:0.007608:0.007644:0.003540:0.003281:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003293:0.002352:0.007173:0.003281:0.008032:0.003293:0.007914:0.007644:0.007173:0.007644:0.003540:0.008032:0.002352:0.003281:0.008032:0.008055:0.007150:0.002352:0.003986:0.003293:0.008020:0.007702:0.008020:0.007150:0.002352:0.008032:0.003986:0.002352:0.007702:0.007173:0.003257:0.003281:0.005009:0.007173:0.007644:0.003257
Kalixanda study: A random population-based study. :@0.101402:0.933632:0.408895:0.933632:0.408895:0.921357:0.101402:0.921357:0.006950:0.008032:0.002352:0.002352:0.005644:0.008032:0.007173:0.008055:0.008032:0.004551:0.005856:0.003986:0.007150:0.008055:0.006303:0.003257:0.004551:0.008702:0.004551:0.003540:0.008032:0.007173:0.008055:0.007702:0.011030:0.004551:0.008020:0.007702:0.008020:0.007150:0.002352:0.008032:0.003986:0.002352:0.007702:0.007173:0.003904:0.008020:0.008032:0.004563:0.007644:0.008055:0.004551:0.004563:0.003986:0.007150:0.008055:0.006303:0.003257:0.003257
Am J Epide-:@0.410188:0.933632:0.480967:0.933632:0.480967:0.921357:0.410188:0.921357:0.008702:0.011030:0.004551:0.005668:0.004551:0.006303:0.008020:0.002352:0.008055:0.007644:0.003904
miol.:@0.101402:0.944587:0.128096:0.944587:0.128096:0.932312:0.101402:0.932312:0.011030:0.002352:0.007702:0.002352:0.003257
 2006;163:1025-1034.:@0.128096:0.944587:0.242748:0.944587:0.242748:0.932312:0.128096:0.932312:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.006515:0.003257
6. :@0.519056:0.082231:0.532085:0.082231:0.532085:0.069955:0.519056:0.069955:0.006515:0.003257:0.003257
Talley  NJ. Functional dyspepsia:  New insights into pathogenesis :@0.544256:0.082231:0.927078:0.082231:0.927078:0.069955:0.544256:0.069955:0.005009:0.008032:0.002352:0.002352:0.007644:0.006303:0.003257:0.003328:0.008702:0.005668:0.003257:0.006573:0.005703:0.007150:0.007173:0.007608:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.006573:0.008055:0.006303:0.004563:0.008020:0.007644:0.008020:0.004563:0.002352:0.008032:0.003257:0.003257:0.003328:0.008702:0.007644:0.009772:0.006573:0.002352:0.007173:0.004563:0.002352:0.007914:0.007173:0.003986:0.004563:0.006573:0.002352:0.007173:0.003986:0.007702:0.006573:0.008020:0.008032:0.003986:0.007173:0.007702:0.007914:0.007644:0.007173:0.007644:0.004563:0.002352:0.004563:0.003257
and therapy. :@0.544256:0.093132:0.622031:0.093132:0.622031:0.080857:0.544256:0.080857:0.008032:0.007173:0.008055:0.003304:0.003986:0.007173:0.007644:0.003540:0.008032:0.008020:0.006303:0.003257:0.003257
Korean J Intern Med.:@0.622067:0.093132:0.740588:0.093132:0.740588:0.080857:0.622067:0.080857:0.006950:0.007702:0.003540:0.007644:0.008032:0.007173:0.003293:0.005668:0.003293:0.002658:0.007173:0.003986:0.007644:0.003540:0.007173:0.003293:0.010807:0.007644:0.008055:0.003257
 2016;31(3):444-456. Doi:10.3904/:@0.740588:0.093132:0.923809:0.093132:0.923809:0.080857:0.740588:0.080857:0.003304:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257:0.003328:0.008749:0.007702:0.002352:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.005139
kjim.2016.091 https://www.ncvi.nim.nih.gov/pubmed/27048251.:@0.544256:0.104034:0.903536:0.104034:0.903536:0.091758:0.544256:0.091758:0.005903:0.002387:0.002352:0.011030:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003269:0.007173:0.003986:0.003986:0.008020:0.004563:0.003257:0.005139:0.005139:0.009772:0.009772:0.009772:0.003257:0.007173:0.007608:0.006515:0.002352:0.003257:0.007173:0.002352:0.011030:0.003257:0.007173:0.002352:0.007173:0.003257:0.007914:0.007702:0.006515:0.005139:0.008020:0.007150:0.008020:0.011030:0.007644:0.008055:0.005139:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.006526:0.003257
7. :@0.519056:0.114935:0.532085:0.114935:0.532085:0.102660:0.519056:0.102660:0.006515:0.003257:0.003257
Thurshim M.  pathophysiology of functional dyspepsia. :@0.544256:0.114935:0.864037:0.114935:0.864037:0.102660:0.544256:0.102660:0.005009:0.007173:0.007150:0.003540:0.004563:0.007173:0.002352:0.011030:0.006162:0.010807:0.003257:0.003257:0.002905:0.006961:0.008032:0.003986:0.007173:0.007702:0.008020:0.007173:0.006303:0.004563:0.002352:0.007702:0.002352:0.007702:0.007914:0.006303:0.006162:0.007702:0.003692:0.006162:0.003692:0.007150:0.007173:0.007608:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.006162:0.008055:0.006303:0.004563:0.008020:0.007644:0.008020:0.004563:0.002352:0.008032:0.003257:0.003257
Gut. :@0.866941:0.114935:0.894846:0.114935:0.894846:0.102660:0.866941:0.102660:0.010254:0.007150:0.003986:0.003257:0.003257
2002 :@0.897750:0.114935:0.927066:0.114935:0.927066:0.102660:0.897750:0.102660:0.006515:0.006515:0.006515:0.006515:0.003257
Jul;51 suppl 1:i63-6.:@0.544256:0.125837:0.652452:0.125837:0.652452:0.113561:0.544256:0.113561:0.005668:0.007150:0.002352:0.003257:0.006515:0.006515:0.003257:0.005856:0.007150:0.008020:0.008020:0.002352:0.003257:0.006515:0.003257:0.002352:0.006515:0.006515:0.003904:0.006515:0.003257
8. :@0.519056:0.136738:0.532085:0.136738:0.532085:0.124463:0.519056:0.124463:0.006515:0.003257:0.003257
Walker MM, Talley NJ. The role of duodenal inflammation in func:@0.544256:0.136738:0.919905:0.136738:0.919905:0.124463:0.544256:0.124463:0.011289:0.008032:0.002352:0.005903:0.007644:0.003540:0.004433:0.010807:0.010807:0.003257:0.004433:0.005009:0.008032:0.002352:0.002352:0.007644:0.006303:0.004445:0.008702:0.005668:0.003257:0.004433:0.005009:0.007173:0.007644:0.004433:0.003540:0.007702:0.002352:0.007644:0.004433:0.007702:0.003692:0.004445:0.008055:0.007150:0.007702:0.008055:0.007644:0.007173:0.008032:0.002352:0.004433:0.002352:0.007173:0.002852:0.002852:0.008032:0.011030:0.011030:0.008032:0.003986:0.002352:0.007702:0.007173:0.004433:0.002352:0.007173:0.004445:0.003692:0.007150:0.007173:0.007608
-:@0.919905:0.136738:0.923809:0.136738:0.923809:0.124463:0.919905:0.124463:0.003904
tional dyspepsia. :@0.544256:0.147640:0.643174:0.147640:0.643174:0.135364:0.544256:0.135364:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.003257:0.008055:0.006303:0.004563:0.008020:0.007644:0.008020:0.004563:0.002352:0.008032:0.003257:0.003257
J Clin Gastroenterol.:@0.643186:0.147640:0.758180:0.147640:0.758180:0.135364:0.643186:0.135364:0.005668:0.003257:0.009560:0.002352:0.002352:0.007173:0.003257:0.010254:0.008032:0.004563:0.003986:0.003540:0.007702:0.007644:0.007173:0.003986:0.007644:0.003540:0.007702:0.002352:0.003257
 2017 Jan;51(1):12-18.:@0.758168:0.147640:0.879571:0.147640:0.879571:0.135364:0.758168:0.135364:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.005668:0.008032:0.007173:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
9. :@0.519067:0.158541:0.532097:0.158541:0.532097:0.146266:0.519067:0.146266:0.006515:0.003257:0.003257
stanghellini V, :@0.544267:0.158541:0.628005:0.158541:0.628005:0.146266:0.544267:0.146266:0.005856:0.003986:0.008032:0.007173:0.007914:0.007173:0.007644:0.002352:0.002352:0.002352:0.007173:0.002352:0.004610:0.008255:0.003257:0.003257
et al.:@0.629357:0.158541:0.659238:0.158541:0.659238:0.146266:0.629357:0.146266:0.007644:0.003986:0.004610:0.008032:0.002352:0.003257
 Gastroduodenal disorders. :@0.659238:0.158541:0.819210:0.158541:0.819210:0.146266:0.659238:0.146266:0.004610:0.010254:0.008032:0.004563:0.003986:0.003540:0.007702:0.008055:0.007150:0.007702:0.008055:0.007644:0.007173:0.008032:0.002352:0.004598:0.008055:0.002352:0.004563:0.007702:0.003540:0.008055:0.007644:0.003540:0.004563:0.003257:0.003257
Gastroenterology. :@0.820551:0.158541:0.927102:0.158541:0.927102:0.146266:0.820551:0.146266:0.010254:0.008032:0.004563:0.003986:0.003540:0.007702:0.007644:0.007173:0.003986:0.007644:0.003540:0.007702:0.002352:0.007702:0.007914:0.006303:0.003257:0.003257
2016:150(6):1380-1392.:@0.544267:0.169443:0.670856:0.169443:0.670856:0.157167:0.544267:0.157167:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.006515:0.003257
10.  Moayyedi p, Lacy BE, :@0.519067:0.180344:0.671455:0.180344:0.671455:0.168069:0.519067:0.168069:0.006515:0.006515:0.003257:0.003257:0.005656:0.010807:0.007702:0.008032:0.006303:0.006303:0.007644:0.008055:0.002352:0.004280:0.006961:0.003257:0.004269:0.005433:0.008032:0.007608:0.006303:0.004280:0.006750:0.006303:0.003257:0.003257
et al.:@0.672478:0.180344:0.702018:0.180344:0.702018:0.168069:0.672478:0.168069:0.007644:0.003986:0.004269:0.008032:0.002352:0.003257
 ACG & CAG clinical guidelines: Man-:@0.702018:0.180344:0.923821:0.180344:0.923821:0.168069:0.702018:0.168069:0.004280:0.008702:0.009560:0.010254:0.004269:0.008902:0.004280:0.009560:0.008702:0.010254:0.004280:0.007608:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.004280:0.007914:0.007150:0.002352:0.008055:0.007644:0.002352:0.002352:0.007173:0.007644:0.004563:0.003257:0.004280:0.010807:0.008032:0.007173:0.003904
agement  of  dyspepsia. :@0.544267:0.191245:0.687001:0.191245:0.687001:0.178970:0.544267:0.178970:0.008032:0.007914:0.007644:0.011030:0.007644:0.007173:0.003986:0.003257:0.003669:0.007702:0.003692:0.003257:0.003669:0.008055:0.006303:0.004563:0.008020:0.007644:0.008020:0.004563:0.002352:0.008032:0.003257:0.003257
American  Journal  of  Gastroenterology. :@0.690682:0.191245:0.927102:0.191245:0.927102:0.178970:0.690682:0.178970:0.008702:0.011030:0.007644:0.003540:0.002352:0.007608:0.008032:0.007173:0.003257:0.003669:0.005668:0.007702:0.007150:0.003540:0.007173:0.008032:0.002352:0.003257:0.003669:0.007702:0.003692:0.003257:0.003669:0.010254:0.008032:0.004563:0.003986:0.003540:0.007702:0.007644:0.007173:0.003986:0.007644:0.003540:0.007702:0.002352:0.007702:0.007914:0.006303:0.003257:0.003257
2017 Jul;112 (7):988-1013. DOI: 10.1038/ajg.2017.154.:@0.544267:0.202147:0.838613:0.202147:0.838613:0.189872:0.544267:0.189872:0.006515:0.006515:0.006515:0.006515:0.003257:0.005668:0.007150:0.002352:0.003257:0.006515:0.006515:0.006515:0.003257:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.008749:0.010219:0.002658:0.003257:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.005139:0.008032:0.002387:0.007914:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003257
11.  Longstreth GF, Lacy BE. Approach to the adult with functional dys-:@0.519067:0.213048:0.923821:0.213048:0.923821:0.200773:0.519067:0.200773:0.006515:0.006515:0.003257:0.003257:0.005656:0.005433:0.007702:0.007173:0.007914:0.004563:0.003986:0.003540:0.007644:0.003986:0.007173:0.003528:0.010254:0.005703:0.003257:0.003540:0.005433:0.008032:0.007608:0.006303:0.003540:0.006750:0.006303:0.003257:0.003540:0.008702:0.008020:0.008020:0.003540:0.007702:0.008032:0.007608:0.007161:0.003540:0.003986:0.007702:0.003528:0.003986:0.007173:0.007644:0.003528:0.008032:0.008055:0.007150:0.002352:0.003986:0.003540:0.009772:0.002352:0.003986:0.007173:0.003540:0.003692:0.007150:0.007173:0.007608:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.003540:0.008055:0.006303:0.004563:0.003904
pepsia. UpToDate. Oct 2018. :@0.544267:0.223950:0.710414:0.223950:0.710414:0.211675:0.544267:0.211675:0.008020:0.007644:0.008020:0.004563:0.002352:0.008032:0.003257:0.003257:0.007702:0.008020:0.005009:0.007702:0.008749:0.008032:0.003986:0.007644:0.003257:0.003257:0.010219:0.007608:0.003986:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257